[Clinical features and prognosis of 166 cases of MYC/BCL2 double-expression diffuse large B-cell lymphoma].

S H Tang、L Tian、W Zhao、J Wang、Xiaoyan Ke

2022PubMedMedicine被引 2开放获取

摘要

DEL is a group of aggressive lymphomas with relatively poor PFS. The R-EPOCH regimen may improve the overall prognosis of patients.

引用本文（GB/T 7714）

S H Tang, L Tian, W Zhao, 等. [Clinical features and prognosis of 166 cases of MYC/BCL2 double-expression diffuse large B-cell lymphoma].[J]. PubMed, 2022.

引文网络

参考文献与被引分析加载中…

DOI：https://doi.org/10.3760/cma.j.issn.0253-2727.2022.09.010

本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。